Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
Wushuang Du(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital)
Cited by 32
Related Papers
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling
|Journal of Thoracic Oncology|2016|44
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
|Clinical Epigenetics|2018|36
Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
|Clinical Epigenetics|2020|29